Eli Lilly Slashes Zepbound Weight Loss Drug Prices: What You Need to Know

Описание: Eli Lilly has announced significant price cuts for its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. This move aims to make the medication more accessible to cash-paying patients with valid prescriptions. Starting now, the starting dose of Zepbound vials is available for as low as $299 per month, down from $349. Higher doses are also discounted, with the 5mg dose at $399 and all other doses at $449 per month. This reduction addresses the high list price of roughly $1,086 per month and limited insurance coverage, which have been barriers for many patients.
The announcement comes on the heels of rival Novo Nordisk’s discounts on Wegovy and Ozempic, and follows President Donald Trump’s deals with both companies to lower drug prices and expand access. While Trump’s agreement with Eli Lilly focuses on a multi-dose pen version pending FDA approval, this immediate price cut on single-dose vials could provide faster relief for patients.
Key takeaways:
Zepbound single-dose vials now start at $299/month on LillyDirect.
Discounts aim to address high costs and insurance gaps for weight loss drugs.
Trump’s deals with Eli Lilly and Novo Nordisk promise further price reductions and Medicare coverage for obesity drugs.
Single-dose vials require syringes and needles for self-injection.
Stay informed on the latest developments in weight loss medications and healthcare accessibility. Subscribe for more updates!